Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model
Courtney L. Jones(University of Colorado Denver), William L. Carroll(NYU Langone Health), Wallace Bourgeois(NYU Langone Health), William E. Evans(St. Jude Children's Research Hospital), Teena Bhatla(Newark Beth Israel Medical Center), Danielle S. Bitterman(Brigham and Women's Hospital), Michael J. Garabedian(New York University), Roy Blum(NYU Langone Health), Steven W. Paugh, D. Morrison(NYU Langone Health), Jinhua Wang(NYU Langone Health), Elizabeth A. Raetz(NYU Langone Health), Xin Wen(Shanxi Agricultural University), David T. Teachey(Children's Hospital of Philadelphia)
Cited by 58
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|1.2k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616